Types of hybrid exosome-based DDSs.
| Exosome origin | Combined NP | Assembly strategy | Loaded agent | Application | Ref. |
|---|---|---|---|---|---|
| CT26 | Liposome | Freeze–thaw | ICG/R837 | Cancer therapy | 79 |
| MSC | Liposome | Extrusion | mTHPC | Cancer therapy | 80 |
| Macrophage | Liposome | Extrusion | DOX | Cancer therapy | 81 |
| Fibroblast | Liposome | Freeze–thaw | DTX and GM-CSF | Cancer therapy | 92 |
| L-929 | Liposome | Extrusion | Clodronate | Pulmonary fibrosis treatment | 110 |
| BMSC | Liposome | Freeze–thaw | Polypyrrole NPs | Peripheral neuropathy treatment | 111 |
| Murine melanoma cell | Hollow gold NPs | Incubation, freeze–thaw method, sonication and electroporation | N/A | Photothermal cancer therapy and imaging | 83 |
| HEK293T | Gold NP | Extrusion | N/A | Brain imaging | 84 |
| MSC | Gold NP | Incubation with PEG | N/A | Brain imaging | 86 |
| Macrophage | Iron oxide NP | Surface modification with strep/biotin | DOX and miRNA21 | Cancer therapy | 87 |
| MSC | Iron oxide NP | Cell-mediated process | N/A | Cutaneous wound treatment | 98 |
| MDA-MB-231 | MOF | Sonication and extrusion | Protein drug | Cancer therapy | 85 |
| H22 and Bel7402 | MPS | Cell-mediated process | DOX | Cancer therapy | 93 |